Aurion Biotech
We're on a mission to cure blindness with our transformational platform of advanced therapies
94 employees · est. 2022 · Seattle, United States
Aurion Biotech is the larger of the two.
Side-by-Side Comparison
| Metric | Aurion Biotech | Emmecell |
|---|---|---|
| Founded | ||
| Founded | 2022 | Not tracked yet |
| Headquarters | ||
| Headquarters | Seattle, United States | Menlo Park, United States |
| Employees | ||
| Employees | 94 larger | 11 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Acquired | Not tracked yet |
| Total Funding | ||
| Total Funding | $120.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 2 | Not tracked yet |
| Services | ||
| Services | Development of cell therapy treatments, Clinical trial execution, Regulatory and quality management, Manufacturing advanced therapies | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with corneal endothelial diseases, Ophthalmologists, Healthcare providers specializing in vision care, Clinical researchers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biotech, Clinical Stage, Advanced Therapies, Corneal Endothelial Disease, Cell Therapy, Biomedical, Ophthalmology, Clinical Trials, Regenerative Medicine, Innovation, Startup, Investing, Vision Care, Medical Research | Ophthalmology, Cell Therapy, Nanotechnology, Magnetic Cell Delivery, Clinical Trials, CGMP Manufacturing |
| Website | ||
| Website | aurionbiotech.com | emmecell.com |
About Aurion Biotech
Aurion Biotech, founded in 2022, is a promising clinical-stage biotech company, headquartered in the United States, with a clear mission embodied in its slogan: "We're on a mission to cure blindness with our transformational platform of advanced therapies." Specializing in biopharma and biotechnolo...
About Emmecell
Emmecell, a privately-held, clinical stage biotechnology company, is gaining attention in the field of cell-based therapies with their innovative magnetic cell delivery platform. Their lead product, EO2002, is designed to tackle corneal edema, a prevalent indication for corneal transplantation. By l...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Aurion Biotech and Emmecell — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Aurion Biotech and Emmecell — by email.
Frequently Asked Questions
Compare Aurion Biotech with someone else
Start typing a company name or domain.